We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.5B
AUM Growth
-$232M
Cap. Flow
-$540M
Cap. Flow %
-2.92%
Top 10 Hldgs %
27.76%
Holding
3,069
New
24
Increased
234
Reduced
2,759
Closed
38

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$41.7M
2
DOCU
DocuSign
DOCU
+$18.2M
3
APO icon
Apollo Global Management
APO
+$17.5M
4
FLEX icon
Flex
FLEX
+$16.1M
5
WDAY icon
Workday
WDAY
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 29.77%
2 Financials 13.35%
3 Consumer Discretionary 11.87%
4 Industrials 10.17%
5 Healthcare 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CABA icon
2826
Cabaletta Bio
CABA
$463M
$50.6K ﹤0.01%
22,306
-1,403
-6% -$4.93K
SBT
2827
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$50.3K ﹤0.01%
10,577
-799
-7% -$3.78K
CERT icon
2828
Certara
CERT
$1.15B
$50K ﹤0.01%
4,695
-499
-10% -$5.42K
WALD icon
2829
Waldencast
WALD
$168M
$49.6K ﹤0.01%
12,343
-716
-5% -$2.51K
RGLS
2830
DELISTED
Regulus Therapeutics
RGLS
$49.6K ﹤0.01%
31,397
-2,370
-7% -$3.64K
PAYS icon
2831
Paysign
PAYS
$735M
$49.4K ﹤0.01%
16,370
-1,236
-7% -$4.33K
MGX icon
2832
Metagenomi Therapeutics
MGX
$43.8M
$49.1K ﹤0.01%
13,602
+10,228
+303% +$24.7K
POWW icon
2833
Outdoor Holding Co
POWW
$247M
$49.1K ﹤0.01%
44,596
-3,368
-7% -$4.01K
OBIO icon
2834
Orchestra BioMed
OBIO
$368M
$48.8K ﹤0.01%
12,208
-215
-2% -$1.16K
PAMT
2835
PAMT Corp
PAMT
$280M
$48.6K ﹤0.01%
2,966
-225
-7% -$3.91K
TTEC icon
2836
TTEC Holdings
TTEC
$62.6M
$48.6K ﹤0.01%
9,732
-735
-7% -$3.84K
AMTX icon
2837
Aemetis
AMTX
$145M
$48.5K ﹤0.01%
18,013
-1,360
-7% -$4.27K
ADVM
2838
DELISTED
Adverum Biotechnologies
ADVM
$48.3K ﹤0.01%
10,343
-780
-7% -$5.25K
ISPR icon
2839
Ispire Technology
ISPR
$85.5M
$48K ﹤0.01%
9,550
-721
-7% -$4.42K
LNAI
2840
Lunai Bioworks
LNAI
$10.8M
$48K ﹤0.01%
719
+384
+115% +$25.5K
VRA icon
2841
Vera Bradley
VRA
$89.3M
$48K ﹤0.01%
12,201
-1,509
-11% -$7.53K
KYTX icon
2842
Kyverna Therapeutics
KYTX
$449M
$47.9K ﹤0.01%
12,811
+3,810
+42% +$18.3K
CART icon
2843
Maplebear
CART
$11.3B
$47.9K ﹤0.01%
1,156
-125
-10% -$5.42K
FLNA
2844
Filana Therapeutics
FLNA
$37.3M
$47.7K ﹤0.01%
20,191
-1,524
-7% -$26.8K
AXS icon
2845
AXIS Capital
AXS
$7.17B
$47.2K ﹤0.01%
533
-45
-8% -$3.85K
GRWG icon
2846
GrowGeneration
GRWG
$90.1M
$47K ﹤0.01%
27,822
-2,879
-9% -$5.51K
TAL icon
2847
TAL Education Group
TAL
$6.55B
$47K ﹤0.01%
4,691
-628
-12% -$6.6K
IGMS
2848
DELISTED
IGM Biosciences
IGMS
$46.6K ﹤0.01%
7,625
-487
-6% -$5.79K
RILY icon
2849
BRC Group Holdings
RILY
$265M
$46.6K ﹤0.01%
10,147
-767
-7% -$4K
CACC icon
2850
Credit Acceptance
CACC
$6.27B
$46.5K ﹤0.01%
99
-5
-5% -$2.32K

Similar funds

Corebridge Financial's Q4 2024 Portfolio in Review

As of Q4 2024, Corebridge Financial held 3,069 positions worth $18.5B, down 1.2% from $18.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 2%. Corebridge Financial opened 24 new positions and exited 38, leaving the 3,069-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corebridge Financial's largest Q4 2024 buy was Apollo Global Management: 110,177 shares worth $18.2M.
  • Corebridge Financial added most to iShares MSCI EAFE ETF in Q4 2024, an estimated $41.7M increase.
  • Corebridge Financial's biggest Q4 2024 reduction was Apple, cutting an estimated $36.8M.
  • Corebridge Financial fully exited Southwestern Energy Company in Q4 2024, selling an estimated $9.27M.
  • Corebridge Financial's ten largest holdings make up 28% of its $18.5B portfolio in Q4 2024.
  • Corebridge Financial opened 24 new positions and closed 38 in Q4 2024.
  • Corebridge Financial's portfolio value fell 1.2% quarter-over-quarter to $18.5B.

Based on Corebridge Financial's 13F filing for Q4 2024, filed 11 Feb 2025.